Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Boyd

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Journal of Intensive Care Medicine|January 3, 2023
Association Between Patient Race and Ethnicity and Outcomes With COVID-19: A Retrospective Analysis From a Large Mid-Atlantic Health SystemAnirudh Rao, Muhtadi H Alnababteh, Victor J Avila-Quintero, et al.
Emerging Infectious Diseases|March 31, 2010
Hypervirulent Clostridium difficile strains in hospitalized patients, CanadaMichael R Mulvey, David A Boyd, Denise Gravel, et al.
Proteomics. Clinical Applications|December 25, 2019
Detection of Antimicrobial Resistance Using Proteomics and the Comprehensive Antibiotic Resistance Database: A Case StudyChih-Yu Chen, Clifford G Clark, Stacie Langner, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2017
Enterobacter cloacae Complex Isolates Harboring <i>bla</i><sub>NMC-A</sub> or <i>bla</i><sub>IMI</sub>-Type Class A Carbapenemase Genes on Novel Chromosomal Integrative Elements and PlasmidsDavid A Boyd, Laura F Mataseje, Ross Davidson, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|February 21, 2023
Genetic and Phenotypic Characterization of the First Canadian Case of Ambler Class A Carbapenemase FRI-8Laura F Mataseje, Florence Doualla-Bell, David A Boyd, et al.
Peerj|January 21, 2025
What 'unexplored' means: mapping regions with digitized natural history records to look for 'biodiversity blindspots'Laymon Ball, Sheila Rodríguez-Machado, Diego Paredes-Burneo, et al.
Journal of Infection Prevention|February 7, 2022
Absence of transmission of NDM and OXA-48 carbapenemase genes in a chronic care unit of a long-term care facilityCarl Boodman, Natalie Gibson, Davenna Conrod, et al.
Emerging Infectious Diseases|June 6, 2013
Ciprofloxacin-resistant Salmonella enterica serovar Kentucky in CanadaMichael R Mulvey, David A Boyd, Rita Finley, et al.
The Journal of Antimicrobial Chemotherapy|October 13, 2018
Results from the Canadian Nosocomial Infection Surveillance Program for detection of carbapenemase-producing Acinetobacter spp. in Canadian hospitals, 2010-16David A Boyd, Laura F Mataseje, Linda Pelude, et al.
Antimicrobial Agents and Chemotherapy|September 8, 2016
Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014Laura F Mataseje, Kahina Abdesselam, Julie Vachon, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of Intensive Care Medicine|January 3, 2023
Association Between Patient Race and Ethnicity and Outcomes With COVID-19: A Retrospective Analysis From a Large Mid-Atlantic Health SystemAnirudh Rao, Muhtadi H Alnababteh, Victor J Avila-Quintero, et al.
Emerging Infectious Diseases|March 31, 2010
Hypervirulent Clostridium difficile strains in hospitalized patients, CanadaMichael R Mulvey, David A Boyd, Denise Gravel, et al.
Proteomics. Clinical Applications|December 25, 2019
Detection of Antimicrobial Resistance Using Proteomics and the Comprehensive Antibiotic Resistance Database: A Case StudyChih-Yu Chen, Clifford G Clark, Stacie Langner, et al.
Antimicrobial Agents and Chemotherapy|February 23, 2017
Enterobacter cloacae Complex Isolates Harboring <i>bla</i><sub>NMC-A</sub> or <i>bla</i><sub>IMI</sub>-Type Class A Carbapenemase Genes on Novel Chromosomal Integrative Elements and PlasmidsDavid A Boyd, Laura F Mataseje, Ross Davidson, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|February 21, 2023
Genetic and Phenotypic Characterization of the First Canadian Case of Ambler Class A Carbapenemase FRI-8Laura F Mataseje, Florence Doualla-Bell, David A Boyd, et al.
Peerj|January 21, 2025
What 'unexplored' means: mapping regions with digitized natural history records to look for 'biodiversity blindspots'Laymon Ball, Sheila Rodríguez-Machado, Diego Paredes-Burneo, et al.
Journal of Infection Prevention|February 7, 2022
Absence of transmission of NDM and OXA-48 carbapenemase genes in a chronic care unit of a long-term care facilityCarl Boodman, Natalie Gibson, Davenna Conrod, et al.
Emerging Infectious Diseases|June 6, 2013
Ciprofloxacin-resistant Salmonella enterica serovar Kentucky in CanadaMichael R Mulvey, David A Boyd, Rita Finley, et al.
The Journal of Antimicrobial Chemotherapy|October 13, 2018
Results from the Canadian Nosocomial Infection Surveillance Program for detection of carbapenemase-producing Acinetobacter spp. in Canadian hospitals, 2010-16David A Boyd, Laura F Mataseje, Linda Pelude, et al.
Antimicrobial Agents and Chemotherapy|September 8, 2016
Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014Laura F Mataseje, Kahina Abdesselam, Julie Vachon, et al.
Pageof 7